HTLV-I-Associated Myelopathy: Clinical Trials

4 trials for HTLV-I-Associated Myelopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 1 completed. 3 Phase 2, 2 Phase 3, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1
Phase 32Completed 1, Terminated 1
Not applicable1Terminated 1

Follow HTLV-I-Associated Myelopathy: new trials by email Literature Review of HTLV-I-Associated Myelopathy trials Research Report on HTLV-I-Associated Myelopathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Tamibarotene - HTLV-I-Associated Myelopathy
Phase 2 / Phase 3TerminatedSt. Marianna University School of Medicine152011-01-012026-10-08
The HAM Infliximab Study
Infliximab - HTLV-I-associated Myelopathy
Phase 2TerminatedImperial College London32008-10-012013-04-15
Safety and Efficiency Study of Valproic Acid In HAM/TSP
Valproic Acid - HTLV-I-Associated Myelopathy
Not applicableTerminatedUniversity Hospital Pierre Zobda-Quitman192006-03-012007-08-22
Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial
Zidovudine/lamivudine, Placebos - HTLV-I-associated Myelopathy
Phase 2 / Phase 3CompletedImperial College London161999-11-082021-08-25

Narrower conditions

Paraparesis, Tropical Spastic (4)

Broader conditions

Central Nervous System Diseases (4)  ·  Central Nervous System Infections (4)  ·  Deltaretrovirus Infections (4)  ·  HTLV-I Infections (4)  ·  Infections (4)  ·  Myelitis (4)  ·  Nervous System Diseases (4)  ·  Neuroinflammatory Diseases (4)  ·  RNA Virus Infections (4)  ·  Retroviridae Infections (4)  ·  Spinal Cord Diseases (4)  ·  Virus Diseases (4)

Interventions

Infliximab (1)  ·  Valproic Acid (1)  ·  lamivudine, zidovudine drug combination (1)  ·  tamibarotene (1)

Sponsors

Imperial College London (2)  ·  St. Marianna University School of Medicine (1)  ·  University Hospital Pierre Zobda-Quitman (1)

Countries

United Kingdom (2)  ·  Japan (1)

Top investigators

Graham P Taylor, FRCP (1)  ·  Graham P Taylor, MD (1)  ·  Yoshihisa Yamano, MD (1)

Results publications

PMID 16984654, PMID 17717136